(Q37809782)

23 August 2017

Treatment of respiratory syncytial virus with palivizumab: a systematic review (English)

1 reference

23 August 2017

1 reference

Jia Hu

1

1 reference

PubMed ID

21080142

23 August 2017

Joan L Robinson

series ordinal

2

1 reference

23 August 2017

16 November 2010

1 reference

World Journal of Pediatrics

23 August 2017

1 reference

23 August 2017

6

1 reference

23 August 2017

4

1 reference

23 August 2017

296-300

1 reference

https://scigraph.springernature.com/pub.10.1007/s12519-010-0230-z

23 August 2017

0 references

cites work

Community respiratory virus infections in immunocompromised patients with cancer

1 reference

12 December 2020

Respiratory syncytial virus-related pneumonia after stem cell transplantation successfully treated with palivizumab and steroid therapy

1 reference

12 December 2020

Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients

1 reference

12 December 2020

Safety and pharmacokinetics of palivizumab therapy in children hospitalized with respiratory syncytial virus infection.

1 reference

12 December 2020

Impact of respiratory syncytial virus in the United States

1 reference

12 December 2020

Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group

1 reference

12 December 2020

A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients

1 reference

12 December 2020

Safety and antiviral activity of motavizumab, a respiratory syncytial virus (RSV)-specific humanized monoclonal antibody, when administered to RSV-infected children

1 reference

12 December 2020

Palivizumab treatment of respiratory syncytial virus infection after allogeneic hematopoietic stem cell transplantation

1 reference

12 December 2020

Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein

1 reference

12 December 2020

Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection

1 reference

12 December 2020

Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group

1 reference

12 December 2020

Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopoietic stem cell transplantation

1 reference

12 December 2020

Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease

1 reference

12 December 2020

Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy children

1 reference

12 December 2020

Prolonged shedding of respiratory syncytial virus in immunocompromised children: implication for hospital infection control

1 reference

12 December 2020

Cost effectiveness of respiratory syncytial virus prophylaxis: a critical and systematic review

1 reference

12 December 2020

Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants.

1 reference

12 December 2020

From the American Academy of Pediatrics: Policy statements--Modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections

1 reference

12 December 2020

10.1007/S12519-010-0230-Z

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

21080142